IDH2 and central nervous system cancer: Homozygous deletion of CDKN2A/B is known to be a common gene alteration in GBM [161,166], but subsequent analysis has shown that it is a characteristic of IDH-mutant gliomas, especially astrocytomas [155,169,170,171,172].